Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Bayer and Johnson & Johnson are facing a wrongful death lawsuit, alleging that their blood thinner Xarelto (rivaroxaban) is dangerous and should not be sold.
A Florida widow filed a Xarelto bleeding wrongful death lawsuit on behalf of her deceased husband, Ronald H. against the manufacturer Janssen Pharmaceutical, a subsidiary of Johnson & Johnson and the co-marketer of Xarelto, and Bayer Healthcare AG, alleging these companies failed to warn of the increased risks of irreversible internal bleeding when using Xarelto.
According to the Xarelto lawsuit, Ronald started using Xarelto in 2012. In January 2013, Ronald suffered a bleeding episode that was allegedly a direct result of using Xarelto. His condition deteriorated after the internal bleeding event and he entered hospice care and died on May 8, 2013.
The Xarelto lawsuit claims that Bayer and Janssen continued to sell it even though they knew the dangerous risks. The Xarelto lawsuit further accuses the defendants of purposely concealing important safety information and failing to test the drug enough before it was put on the market.
Approved in 2011, Xarelto is one of the newest anticoagulants. Xarelto has been widely prescribed to prevent blood clots in patients suffering from atrial fibrillation (arrhythmia of the heart), deep vein thrombosis (deep blood clots), pulmonary bleeding, stroke, and in patients who have recently undergone a knee or hip replacement surgery.
It generally is prescribed as an alternative to Warfarin (coumadin), a blood thinner that began to be used in 1954. Vitamin K is coumadin’s reversal agent. Xarelto does not have one.
Other potential injuries caused through the use of Xarelto include thrombosis (blood clots), decreased hemoglobin (a substance that carries oxygen in red blood cells), cerebrovascular accidents (an event that leads to a cerebral hemorrhage), hematoma (a semisolid mass in the blood), peripheral edema (swelling of the lower limbs), and dyspnea (difficulty breathing).
The Xarelto Lawsuit is Case No. 3:15-cv-00554-MMH-MCR, in the U.S. District Court for the Middle District of Florida Jacksonville Division.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Xarelto attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Xarelto class action lawsuit is best for you. [In general, Xarelto lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
Get Help – It’s Free
Join a Free Xarelto Class Action Lawsuit Investigation
If you or a loved one took Xarelto (rivaroxaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, deep vein thrombosis or pulmonary embolism, you may have a legal claim. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
